You are on the way to your cubicle, coming back from the cafeteria, when you run into Nick. He says he has to fly to Vancouver for a meeting with the solar panel supplier for the new power station project. Nick knows you’ve been to Vancouver a few times to visit your brother, so he asks you to recommend a couple good restaurants to hit when he’s in there. Your brain scans thru all the times you were there, cross references the places you ate, and compares them.
Continuing “brain fog” and other neurological symptoms after COVID -19 recovery may be due to post-traumatic stress disorder (PTSD), a new report indicates1. Such brain fog was an effect observed in past human coronavirus outbreaks such as SARS and MERS. People who have recovered from COVID-19 sometimes experience persistant troubles with concentration, as well as headaches, anxiety, fatigue or sleep disruptions. Patients may fear that the infection has permanently damaged their brains, but researchers say that’s not necessarily the case.
A part of the mouse brain called the supramammillary nucleus (SuM) is specialized for detecting new experiences, researchers at the RIKEN Center for Brain Science (CBS) in Japan have found1. Within the SuM, responses to experiences related to unknown individuals — called social novelty — were separated from those related to unfamiliar places — called context novelty — before being sent to distinct parts of the brain’s main memory-formation center. The finding may further the understanding of normal memory, as well as conditions in which recognizing and reacting to new information is impaired.
Unexplained repeated pregnancy loss is a poorly understood condition that can cause significant distress and for which no effective treatment exists. Much research to date has focused on dysfunctions of the uterus or hormonal signaling (Saravelos and Regan, 2014), but the possible involvement of the nervous system has not been explored despite the role of the olfactory system in mammalian reproduction being well-documented (Dulac and Torello, 2003). Exposing female rodents to the smell of adult males can lead to synchronized menstrual cycling (Whitten, 1956) and accelerated sexual maturation (Vandenbergh, 1967), as well as to embryos failing to implant in the uterus (Bruce, 1959).
Is it possible to model the habits of serenity? Would a person who is highly serene even have any habits? Or are people who are habitually calm actually living in a numbed-out cocoon? Can you genuinely feel a sense of serenity on a regular basis? Sometimes it seem like feelings of anxiety have become normal in nearly all aspects of life . People aren’t able to enjoy feelings of calmness and peace on any regular basis.
Venetoclax, (brand names Venclexta and Venclyxto) is an oral medication used to treat adults with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or acute myeloid leukemia (AML). Venetoclax attaches to the protein Bcl-2. This protein is present in high amounts in CLL cancer cells, where it helps the cells survive for longer in the body and makes them resistant to cancer medicines. By attaching to Bcl-2 and blocking its actions, venetoclax causes the death of cancer cells and thereby slows down progression of the disease.
A significant change in the purpose of sleep happens at the age of about 2 and a half, a UCLA-led team of scientists has discovered. Prior to that age, the brain grows very rapidly. During REM sleep, when vivid dreams occur, the young brain is busy building and strengthening synapses — the structures that connect neurons to one another and allow them to communicate. “Don’t wake babies up during REM sleep—important work is being done in their brains as they sleep,”
Sunitinib (brand name Sutent) is a medication used to treat cancer. It is a small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications. Gastrointestinal Stromal Tumor Like RCC, gastrointestinal stromal tumor does not typically respond to standard chemotherapy or radiation.